Favipiravir

Category:Active Pharmaceutical Ingredients > Antibiotics > Other Antibiotics
Product Name:Favipiravir
CAS No.:259793-96-9
Standard:In-house Standards
Price(USD):Negotiable
Company:Quanzhou Fortune Biopharma Co.,Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: QUANZHOU

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Favipiravir, as a new broad-spectrum anti-rna virus drug, was approved to be marketed in Japan in March 2014 for the antiviral treatment of influenza a and b.

    Research shows that in addition to influenza virus, familavir also shows good antiviral activity against a variety of RNA viruses, such as ebola virus, sand virus, bunya virus, rabies virus.Recent studies have shown that fabivir has a certain inhibitory effect on COVID-19.

Send your message to this supplier
  • From:
  • To:
    Quanzhou Fortune Biopharma Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service